Haynes and Boone, LLP Intellectual Property Partner Paul Dietze commented to Law360 about the impact of a recent Federal Circuit decision that applied the printed matter doctrine to invalidate a respiratory drug patent.
"A practice tip is when drafting claims, you want to make sure you do something functional with the information,” Dietze said. "Take some action, like lowering a dose, rather than telling people the information."
To read the full article, click here. (Subscription required)